Emmanuel J Favaloro/LinkedIn
Nov 15, 2025, 15:41
Emmanuel J. Favaloro: Transitioning Patients from DOACs to Heparin
Emmanuel J Favaloro, Editor in Chief of Seminars in Thrombosis and Hemostasis, shared a post on LinkedIn:
“Transitioning of Patients from Direct-Acting Oral Anticoagulant to Heparin: Impact on Laboratory Testing. This Commentary has just been released online, and is free to download from.”
Title: Transitioning of Patients from Direct-Acting Oral Anticoagulant to Heparin: Impact on Laboratory Testing
Authors: Deepa J. Arachchillage, Saravanan Vinayagam, Annie Parsons, Nilanthi Karawitage, Mike Laffan
Read the full article here.
Stay updated with Hemostasis Today.
-
Jan 10, 2026, 15:02Dr Manikanta Receives AHA Fellowship to Investigate Platelet-Dependent Nucleic Acid-Sensing Pathways
-
Jan 10, 2026, 14:40Last day at ASH25 from Riten Kumar
-
Jan 10, 2026, 08:56Shivanand Kumatagi Reflects on His Visit to Rela Hospital
-
Jan 10, 2026, 08:48Mitchell Elkind: Why Is The American Heart Association Holding a Brain Health Symposium?
-
Jan 10, 2026, 08:41Fiona Robinson Invites You to NBDF Webinar on Research Grants
-
Jan 10, 2026, 08:30Melissa Korn Takes Front Page Award for Her WSJ Piece on Experiencing a Pulmonary Embolism
-
Jan 10, 2026, 08:20Aymar Akilimali on Malaria in the Democratic Republic of Congo
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome